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ABSTRACT: ATP7A and ATP7B are P-type ATPases required for copper homeostasis and involved in the
etiology of Menkes and Wilson diseases. We used heterologous expression of ATP7A or ATP7B in COS-1
cells infected with adenovirus vectors to characterize differential features pertinent to each protein expressed
in the same mammalian cell type, rather than to extrinsic factors related to different cells sustaining
expression. Electrophoretic analysis of the expressed protein, before and after purification, prior or
subsequent to treatment with endoglycosidase, and evidenced by protein or glycoprotein staining as well
as Western blotting, indicates that the ATP7A protein is glycosylated while ATP7B is not. This is consistent
with the prevalence of glycosylation motifs in the ATP7A sequence, and not in ATP7B. ATP7A and ATP7B
undergo copper-dependent phosphorylation by utilization of ATP, forming equal levels of an “alkali labile”
phosphoenzyme intermediate that undergoes similar catalytic (P-type ATPase) turnover in both enzymes. In
addition, incubation with ATP yields an “alkali stable” phosphoprotein fraction, attributed to phosphoryla-
tion of serines. Alkali stable phosphorylation occurs at lower levels in ATP7A, consistent with a different
distribution of serines in the amino acid sequence. Immunostaining of COS-1 cells sustaining heterologous
expression shows initial association of both ATP7A and ATP7B with Golgi and the trans-Golgi network.
However, in the presence of added copper, ATP7A undergoes prevalent association with the plasma
membrane while ATP7B exhibits intense trafficking with cytosolic vesicles. Glycosylation of ATP7A and
phosphorylation of ATP7B apparently contribute to their different trafficking and membrane association
when expressed in the same cell type.
The human copper ATPases ATP7A and ATP7B sustain
essentialrolesincopperhomeostasis,includingintracellularcopper
delivery for inclusion in metalloproteins, membrane trafficking,
and exportofexcesscopper fromcells(1).Thecatalyticmechanism
and related structural features of both ATP7A and ATP7B are
similar to those of P-ATPases (2), which are members of the acid
dehalogenase superfamily (3). The mechanism of P-ATPases is
based on the presence of transmembrane segments with a binding
site (TMBS)
1 for the metal undergoing active transport, and a
headpiece that protrudes from the membrane. In analogy to other
P-type ATPases, the headpiece of ATP7A and ATP7B includes an
Nd o m a i nw i t ht h eA T Pb i n d i n gs i t e ,aPd o m a i nw i t ha na s p a r t y l
residue undergoing phosphorylation as an intermediate step in
the catalytic cycle, and an A domain containing the conserved
TGE motif required for catalytic assistance of the final hydrolytic
reaction. A specific feature of mammalian copper ATPases is
an amino-terminal extension (NMBD) that includes six copper
binding sites in addition to the TMBS (1). This N-terminal
extension is involved in interactions with chaperone proteins (4)
and undergoes copper-induced and functionally relevant confor-
mational effects (5), which are required for mammalian copper
homeostasis.
Much progress in the characterization of ATP7A (Menkes
diseaseprotein)andATP7B(Wilsondiseaseprotein)wasrealized
byheterologousexpressionininsectcells(6,7),includingdemon-
stration of a phosphorylated enzyme intermediate formed by
utilizationofATP.Furthermore,animportantfeatureofATP7B
is the presence of serine residues undergoing phosphorylation
and possibly involved in functionally relevant interactions (6).
ATP7A and ATP7B exhibit trafficking patterns that are likely
to be relevant to their functions. Following initial localization in
the trans-Golgi network (8), the two proteins undergo specific
targetinginresponsetocopper.TheATP7Aproteinisdirectedto
the basolateral membrane in polarized cells(9, 10), while ATP7B
was shown to be associated with cytosolic vesicles (11)a n dt o
target the apical membrane in hepatoma cells (12). It is possible
that post-translational modification may influence specific traf-
ficking (13, 14), but the extent to which intrinsic features of the
two proteins, or different cell types sustaining expression, are
responsible for different trafficking patterns is not clear.
With the experiments reported here, we have obtained hetero-
logous expression of ATP7A and ATP7B in the same mamma-
lian cell line (COS-1) infected with adenovirus vectors and
characterized features pertinent to each protein expressed in
the same cell type, in a manner independent of extrinsic factors
†This work was supported by National Institutes of Health Grant
RO1-69830.
*To whom correspondence should be addressed: CPMCRI, 475
Brannan St., San Francisco, CA 94107. Phone: (415) 600-1745. Fax:
(415) 600-1725. E-mail: ginesi@cpmcri.com.
1Abbreviations: NMBD, N-terminal metal binding domain; TMBS,
transmembrane metal binding site; BCA, bicinchoninic acid; SDS,
sodium dodecyl sulfate; NP-40, nonyl phenoxypolyethoxylethanol;
DTT, dithiothreitol; HEPES, 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid; MOPS, 3-(N-morpholino)propanesulfonic acid; FBS,
fetal bovine serum; DMEM, Dulbecco’s modified Eagle’s medium;
EDTA, ethylenediaminetetraacetic acid; DAPI, 40,6-diamidino-2-phe-
nylindole; PBS, phosphate-buffered saline.Article Biochemistry, Vol. 49, No. 46, 2010 10007
that may be related to different cell types sustaining expression.
We observed significant differences with regard to glycosylation
and phosphorylation, as well as trafficking patterns of ATP7A
and ATP7B in response to copper load, even though the two
proteins were expressed in the same cell type and by identical
procedures.
EXPERIMENTAL PROCEDURES
Methods for construction of recombinant adenovirus vectors
containing CMV promoter-driven ATP7A or ATP7B cDNA
fused with a 30 c-myc tag (rAdATP7Amyc or rAdATP7Bmyc),
infection of COS-1 cells, and immunostaining for detection of the
heterologous ATP7A or ATP7B protein, were previously described
in detail for ATP7B (15). Preparation of the microsomal fraction
from infected COS-1 cells was also described previously (15).
Total protein determination was achieved via the Pierce BCA
assay. SDS gel electrophoresis was performed by the method of
Laemmli(16)atpH8.3orWeberandOsborn(17)atpH6 .3 .Th e
gels were stained with either Coomassie Blue R-250 (Sigma) for
detection of protein bands or Pro-Q Emerald (Invitrogen) for
detectionofglycoprotein.Inaddition,theproteinwastransferred
from the gels to a PDVF membrane for Western blotting, which
was then visualized using 9E10 monoclonal antibodies against
the c-myc tag. In some experiments, before electrophoresis, we
subjected the microsomal protein to deglycosylation by dissol-
ving 50 μg of microsomal protein in 40 μLo fr e a c t i o nb u f f e r
containing50mMsodiumphosphate,0.25%SDS,20mMDTT,
and protease inhibitor cocktail (Sigma) (pH 7.5). Tergitol-type
NP-40 was then added to a final concentration of 1%, followed
by2500 units of endoglycosidase PNGase F (NEB). The mixture
was incubated at 37 C for 4 h. The reaction was stopped via
addition of loading buffer, and the samples were subjected to
electrophoresis and immunoblotting analysis. A parallel incuba-
tion was conducted in the absence of PNGase to serve as a
negative control.
Purification of His-tagged ATP7A protein was achieved via
solubilizing microsomes (5 mg of protein) with 5 mL of solubi-
lization buffer [20 mM Tris, 150 mM NaCl, 1 mM 2-mercap-
toethanol, 20% glycerol, 1% LDS, and protease inhibitor
cocktail (Roche) (pH 7.5)], followed by a 15 min incubation at
room temperature and centrifugation at 12000 rpm for 5 min
(Beckman microfuge). The supernatant was collected and mixed
with 1 mL of nickel affinity resin (Qiagen) and shaken for 1 h.
Unbound proteins were removed by centrifugation at 2000 rpm
for5min,andtheresinwaswashedthreetimeswith1mLofwash
buffer [20 mM Tris, 150 mM NaCl, 5 mM imidazole, 1 mM
2-mercaptoethanol, 20% glycerol, and 0.1% LDS (pH 7.5)]. The
boundproteinwasthenelutedfromtheresinwith1mLofelution
buffer [20 mM Tris, 150 mM NaCl, 100 mM imidazole, 1 mM
2-mercaptoethanol, 20% glycerol, and 0.1% LDS (pH 7.5)] and
shaken gently for 30 min followed by centrifugation at 2000 rpm
for5mintoeliminatetheresin.Asecondelutionstepwasattimes
used to collect residual protein bound to the resin. The entire
procedure was performed at room temperature.
[
32P]Phosphoenzyme formation by utilization of [γ-
32P]ATP
was achieved via incubation of ATP7A or ATP7B (50 μgo f
microsomal protein/mL) with 50 μM[ γ-
32P]ATP at 30 C, in
a reaction mixture containing 50 mM MES triethanolamine
(pH 6.0), 300 mM KCl, 10 mM DTT, and 3 mM MgCl2.N o
copperorvariousconcentrationsofCuCl2orBCSwereadded,as
specified in the figure legends. Samples were quenched at serial
times with 5% trichloroacetic acid, pelleted by centrifugation at
5000 rpm for 5 min, resuspended in pH 8.3 or 6.3 loading buffer,
and separated by Laemmli (16) or Weber-Osborn (17) gel electro-
phoresis. The gels were dried and exposed to a phosphor screen
followed by scanning using a Typhoon scanner (Amersham).
In some cases, [
32P]phosphoenzyme formation was assessed in
microsomes pretreated with λ-protein phosphatase (NEB). The
phosphatase treatment was conducted in 100 μL of reaction
buffer [2400 units of λ-protein phosphatase, 50 mM HEPES,
100 mM NaCl, 2 mM DTT, 0.01% Brij 35, and 1 mM MnCl2
(pH 7.5)] containing 1 mg of microsomal protein at 30 Cf o r
30min.The reactionwasstopped by the additionofphosphatase
inhibitor cocktail (Sigma). The reaction mixture was diluted to
1 mL with microsome resuspension buffer [0.25 M sucrose and
10 mM MOPS (pH 7.0)], mixed by vortexing, and centrifuged at
14000 rpm for 15 min. The pellet was resuspended in microsome
resuspension buffer to a final volume of 200 μL. A parallel
incubation was conducted in the absence of λ-protein phospha-
tase to serve as a negative control.
Immunostaining of COS-1 Cells Sustaining Expression
of ATP7A or ATP7B. COS-1 cells were grown in a 60 mm
culture dish until they reached 60-70% confluence in DMEM
containing 10% FBS, inside a CO2 incubator at 37 C. The cells
were infected with optimal rAdATP7Bmyc viral titers as deter-
mined by preliminary cytotoxicity and expression titrations.
Following incubation for 48 or 72 h in a CO2 incubator, the
cells were detached using a 0.25% trypsin-EDTA solution
(Invitrogen) and reseeded on a sterile coverslip that was placed
ina35mmculturedish.Followingincubationat37CintheCO 2
incubator for an additional 5 h to obtain a uniform cell distribu-
tion, the cells were fixed with 3.7% (v/v) paraformaldehyde in
PBS for 20 min, followed by permeabilization with 0.1% Triton
X-100inPBSfor15minatroomtemperature.Thepermeabilized
COS-1cellswereblockedwith10%horseseruminPBSfor1hat
room temperature followed by the incubation with the diluted
primary anti-myc monoclonal antibody (9E10) at 4 C overnight
in block solution. The primary antibodies were detected by
incubation of the cells with anti-mouse Alexa 488-conjugated
antibodies (Invitrogen) diluted (1:200) in the block solution for
2 h at room temperature. The nuclei of the infected cells were
stained with propidium iodide or DAPI. Each step was followed
bythree rinses withPBS. Finally, the stainedcellswereevaluated
for ATP7Bmyc expression using a confocal laser scanning
microscope (Nikon, Eclipse TE2000-U).
Co-ImmunostainingofthePlasmaMembraneandATP7A
Protein. COS-1 cells were infected with optimal rAdATP7Amyc
viral titers as explained above, and following incubation for 2 h in
aC O 2 incubator, the cells were treated with 200 μM copper, after
24 h fixed with 3.7% (v/v) paraformaldehyde in PBS for 20 min,
and permeabilized with 0.1% Triton in PBS for 15 min. The cells
were then rinsed two additional times before being incubated in
blocking buffer containing 10% horse serum in PBS for 1 h at
room temperature and subsequently incubated with the mouse
anti-Myc tag primary antibody (9E10) (1:500) and rabbitanti-Pan
Cadherin (1:200) diluted in blocking buffer in a humidified
chamber overnight at 4 C. The cells were then washed three
times in PBS and then incubated with Alexa Fluor 555 goat anti-
rabbit and Alexa Fluor 488 goat anti-mouse secondary antibodies
(diluted 1:500 in blocking buffer) for 1 h at room temperature in
the dark. The coverslips were washed and mounted in mounting
medium with either DAPI or propidium iodide before confocal
scanning (Nikon, Eclipse TE2000-U).10008 Biochemistry, Vol. 49, No. 46, 2010 Liu et al.
RESULTS
Characterization in the Microsomal Fraction of COS-1
Cells Sustaining Expression of ATP7A or ATP7B. Similar
levels of ATP7A and ATP7B proteins are shown by electro-
phoretic analysis of microsomal fractions obtained from COS-1
cells sustaining heterologous expression. However, the ATP7A
protein appears as a diffuse band, while ATP7B appears as a
sharpband, as evidencedby proteinstaining or byimmunostain-
ingofthec-myctagpresentinbothproteins(Figure1,toppanel).
If the microsomal proteins are subjected to digestion with
glycosidase before electrophoresis, the ATP7A protein runs as
a single and sharp band that is smaller, while the mobility of the
ATP7B band is not affected at all (Figure 1, top panel). We then
purified the ATP7A, taking advantage of a His tag placed in the
expression construct, and obtained a much better demonstration
of glycosylation (Figure 1, bottom panel). In fact, even the
purified protein exhibits an extended band on protein stain,
Westernblots,andglycoproteinstaining.Followingdeglycosyla-
tion, the ATP7A band becomes compact on protein-stained and
Western-blotted gels and disappears in the glycoprotein-stained
gel.The ratherwideappearanceofthe ATP7A beforeincubation
with glycosidase is likely due to uneven levels of maturity and
glycosylation of the nascent protein at the time of harvesting.
PhosphorylationReactionsfollowingUtilizationofATP
by the Microsomal Fraction of COS-1 Cells Sustaining
Expression of ATP7A or ATP7B. Incubation of microsomal
fractions with[γ-
32P]ATP, quenched at serial times with trichlor-
oacetic acid, results in phosphorylation of ATP7A and ATP7B,
yielding [γ-
32P]phosphoprotein that can be visualized by gel elec-
trophoresis.AspreviouslyreportedforATP7B(15),theresulting
[γ-
32P]phosphoprotein includes an alkali labile component and
an alkali stable component, clearly distinguished by solubiliza-
tion and electrophoresis of the quenched product in acid (17)o r
alkaline (16) buffer. We find that the alkali stable component is
much less prominent for ATP7A than for ATP7B (Figure 2). In
addition, as observed by immunostaining (Figure 1), the ATP7A
[γ-
32P]phosphoproteinband isratherwide,ascompared withthe
sharpATP7B[γ-
32P]phosphoproteinband(Figure2).Inanalogy
with ATP7B (15), formation of both the prominent alkali labile
and the minor alkali stable phosphoprotein of ATP7A iscopper-
dependent (Figure 3).
Formation of the Phosphoenzyme Intermediate. The
alkaline labile portion of the ATP7A and ATP7B phosphopro-
tein is attributed to phosphorylation of the invariant aspartyl
residue of P-type ATPases, yielding the catalytic intermediate of
the ATPase cycle. In fact, we found that alkali labile phosphoen-
zyme is not formed following mutation of the invariant aspar-
tate (15). It is apparent from Figure 4 that formation of alkaline
labile phosphoprotein (i.e., aspartate phosphorylation) is faster
than formation of alkali stable phosphoprotein (i.e., serine phos-
phorylation) and reaches near maximal levels within 1 or 2 s
FIGURE 1: Electrophoretic analysis of microsomal proteins derived
fromCOS-1cellsexpressingATP7AorATP7BandpurifiedATP7A
protein. Protein stain was obtained with Coomassie Blue R-250;
glyocoprotein stain was obtained with Prop_Q Emerald 300, and
Western blots were obtained with 9E10 monoclonal antibodies
against the c-myc tag in the expressed protein. D denotes samples
subjected to deglycosylation before electrophoresis.
FIGURE 2: Phosphorimaging of electrophoretic gels loaded with
ATP7A or ATP7B [
32P]phosphoprotein. The proteins were reacted
with[γ-
32P]ATPat30Ctofollowformationofphosphoproteinasa
function of time. The reaction was stopped with trichloroacetic acid
at sequential times as indicated, and the quenched samples were
dissolved in detergent at acidic or alkaline pH and separated by
electrophoresis atacidic or alkaline pH. Note that the band intensity
is much more intense when the electrophoresis is run at acidic as
compared to alkaline pH, and the residual alkali resistant phospho-
protein is more intense for ATP7B than for ATP7A.
FIGURE 3: Copper dependence ofATP7A phosphorylation. Incuba-
tion of microsomes (derived from COS-1 cells sustaining ATP7A
expression)with[γ-
32P]ATPwasallowedtoproceedfor10sat30C,
in the presence of5 μMa d d e dC u C l 2,n oc o p p e r ,o r5m MB C S .T h e
columnsshowthealkalilabileandalkalistablephosphoproteinlevels
obtainedin the presence of5 μMC u C l 2 (a), noadded (b), and 5 mM
copper chelator BCS (c).Article Biochemistry, Vol. 49, No. 46, 2010 10009
at 30 C. To compare the turnover of the ATP7A and ATP7B
[
32P]phosphoenzyme intermediate, we performed a chase with
nonradioactive ATP and obtained satisfactory time resolution at
10C.WefoundthatforbothATP7AandATP7Bthe[
32P]phos-
phoenzyme intermediate decays with a half-time of approxi-
mately 2 s (Figure 5, left panel), corresponding to forward
turnover.
It should be pointed out that faster kinetics for ATP7A than
ATP7B were previously reported (18). However, the reported
kinetics were on the minute time scale, as opposed to our second
time scale (Figure 4). In addition, using the same type of ATP7B
expression, no serine phosphorylation was observed (6), as
demonstrated following aspartate mutation. It is possible that
expression in insect cells (6, 18) does not include post-transla-
tional modifications that are required for correct folding and
adequate function of the protein. Our expression in mammalian
cells yields kinetics on the second time scale (as expected of an
enzyme),allowsserinephosphorylationofATP7B,andexhibitsa
stoichiometry compatible with the expressed protein.
We also observed that decay of [γ-
32P]phosphoenzyme inter-
mediate formation following a chase with nonradioactive ADP,
corresponding to reverse turnover, is significantly faster (Figure 5,
right panel). This indicates that the observed [
32P]phosphoenzyme
includesmostly the first intermediate in the P-ATPase cycle (E1-P),
before the rate-limiting transition to the conformational isomer
(E2-P) that then undergoes hydrolytic cleavage.
Alkali Stable Phosphoprotein. The residual phosphopro-
tein revealed by electrophoresis at alkaline pH (alkali stable) is
related to phosphorylation of serine residues, as demonstrated
by mass spectrometry (15). Considering that the alkali resistant
phosphoprotein level is lower for ATP7A than for ATP7B
(Figures 3 and 4), we wondered whether phosphorylation of
serines ex vivo (in the cultured cells sustaining expression) may
have limited the number of serines available for phosphorylation
in vitro. To clarify this uncertainty, we preincubated microsomes
containing ATP7A or ATP7B for 30 minat 30C in the presence
or absence of λ-protein phosphatase before performing phos-
phorylationexperimentswith[γ-
32P]ATPinvitro.Wefoundthat
cleavage of the phosphoenzyme formed ex vivo did in fact result
in increased levels of alkali resistant ATP7B phosphorylation in
vitro [from 13 to 24 pmol/mg of microsomal protein produced in
5 min (Figure 6)]. On the other hand, alkali resistant phosphory-
lation of ATP7A occurred at a similarly low level [0.4-0.5 pmol/
mg of microsomal protein produced in 5 min (Figure 6)], with and
without prior incubation with λ-protein phosphatase. These results
clearly show that the level of serine phosphorylation is lower
in ATP7A than in ATP7B. On the other hand, it is important
to note that alkali labile phosphorylation (i.e., phosphoenzyme
FIGURE 4: Time course of ATP7A and ATP7B phosphoenzyme
formation. Microsomes obtained from COS-1 cells sustaining ex-
pressionofATP7AorATP7Bwerereactedwith[γ-
32P]ATPat30C
for sequential times as indicated, to follow formation of [γ-
32P]phos-
phoprotein as a function of time (see Experimental Procedures).
Following acid quenching at sequential times, the quenched samples
were dissolved in detergentat acidicor alkalinepHand separated by
electrophoresis at acidic or alkaline pH. The data show results
obtained with acidic medium electrophoresis (9), alkaline medium
electrophoresis (0), and net alkali labile phosphoprotein (i.e., phos-
phoenzyme intermediate) (b). Note that in all cases the alkaline
stable phosphorylation (serines) occurs at a lower rate than the
alkaline labile phosphorylation (aspartate) and is more prominent
for ATP7B than for ATP7A.
FIGURE 5: Decay of the phosphorylated enzyme intermediate in the
forward and reverse direction of the catalytic cycle. Microsomes
obtained from COS-1 cells sustaining expression of ATP7A (b)o r
ATP7B (O) were reacted with [γ-
32P]ATP at 10 C for 15 s, at which
time1mMnonradioactiveATPorADPwasadded,andthesamples
were acid quenched at various times as indicated. The quenched
samples were dissolved in detergent at acidic or alkaline pH and
separated by electrophoresis at acidic or alkaline pH. The figure
displays residual acid labile [
32P]phosphoprotein (i.e., phosphory-
lated enzyme intermediate) following addition of nonradioactive
ATP (forward direction of the cycle) or ADP (reverse direction of
the cycle).
FIGURE 6: Effectofpreincubationwithλ-proteinphosphataseonthe
levels of ATP7A and ATP7B [γ-
32P]phosphoprotein formed by
utilization of ATP. Microsomes obtained from COS-1 cells sustain-
ing expression of ATP7A or ATP7B were incubated for 30 min at
30 C, in the presence or absence of λ-protein phosphatase (see
Experimental Procedures). Following centrifugation and resuspen-
sion, the microsomal protein (50 μg/mL) was incubated with 50 μM
[γ-
32P]ATP at 30 C, as explained in Experimental Procedures. The
quenched samples were dissolved in detergent at acidic or alkaline
pH and separated by electrophoresis at acidic or alkaline pH.10010 Biochemistry, Vol. 49, No. 46, 2010 Liu et al.
intermediate) reachesapproximatelythesamelevels(4-5nmol/mg
of microsomal protein) in ATP7B and ATP7A, in a manner
independent of preincubation with λ-protein phosphatase
(Figures 4 and 6).
Trafficking Patterns of ATP7A and ATP7B Expressed
inCOS-1Cells. AnimportantfeatureofATP7AandATP7Bis
their copper responsive trafficking (19, 20). To determine
whether intrinsic features of ATP7A or ATP7B expressed in
thesamecelltypemaycontributetodifferenttraffickingpatterns,
we examined by immunostaining COS-1 cells sustaining hetero-
logousexpressionofeitherprotein.Wefoundthat,intheabsence
of added copper (Figure 7A,B), both proteins (green in Figure 7)
were located near the nuclei (red in Figure 7), corresponding to
theGolgiandtrans-Golginetwork.Whenthecellsweresubjected
to a copper load, a significant portion of the ATP7A protein was
shifted toperipheral membranes (Figure7C),while followingthe
same copper load, a prevalent fraction of the ATP7B protein joined
numeroustraffickingvesiclesinthecytoplasm(Figure7D).Wethen
performed additional experiments to obtain microscopic images
with greater resolution and found that ATP7A, identified by immu-
nostaining with an anti-myc tag antibody (green in Figure 8A), is
predominantly localized on plasma membranes identified by im-
munostaining with anti-Pan Cadherin antibody (red in Figure 8B).
Colocalization in the plasma membrane is further demonstrated by
an overlay (Figure 8D). The clearly different trafficking patterns of
ATP7A and ATP7B were observed in experiments performed
several times in parallel, using COS-1 cells infected with the same
viral titers, and maintained under the same conditions.
DISCUSSION
ATP7A and ATP7B are both copper-activated P-type AT-
Pases involved in copper acquisition, delivery of copper to
metalloproteins in the secretory pathway, and export of excess
copper from cells. It is clear that a catalytically active conforma-
tional state of both proteins is important for membrane traffick-
ing and copper transport (1). In fact, in our experiments, the
catalytic properties of the two enzymes, including activation by
copper, a phosphorylated intermediate, and kinetic turnover, are
quite similar (Figures 4 and 5). On the other hand, specific
features of ATP7A and ATP7B are revealed by the diverse
phenotypes of diseases related to defects of either gene. Further-
more, while ATP7A appears to be involved in trafficking to the
basolateral membrane of polarized cells, ATP7B is engaged in
exportofcopperbutalsointhedeliveryofcoppertothesecretory
pathways (1). These specific patterns are likely related, at least in
part,tospecificfeaturesofdifferentcelltypes.Ontheotherhand,
in our experiments, expression of ATP7A and ATP7B in the
same mammalian cell type allowed a comparative evaluation of
intrinsic features of the two proteins. In fact, we observed diffe-
rences in post-translational modifications, inasmuch as ATP7A
undergoes glycosylation, while ATP7B does not (Figure 2).
Furthermore, ATP7A undergoes a much lower level of alkali
stable (serine) phosphorylation than ATP7B (Figures 4 and 6).
The difference in glycosylation is consistent with protein
sequence analysis(Table1) revealingseveralglycosylationmotifs
in ATP7A, including N686MS and N975RS within the cytosolic
loops between transmembrane segments 1 and 3 and segments 5
and 6. These loops are expected to acquireextracellular exposure
upon plasma membrane localization of the ATP7A protein. As
originally shown by Katz et al. (21), newly synthesized and
glycosylated proteins are assembled asymmetrically on rough
FIGURE 7: Cytosolic distribution of ATP7A and ATP7B in COS-1
cells following infection with viral vector in the presence of basal or
addedCuCl2.COS-1cellswereinfectedwithoptimalrAdATP7Amyc
or rAdATP7Bmyc viral titers as explained in Experimental Proce-
dures.ATP7A(AandC)andATP7B(BandD)wereimmunostained
with the primary anti-myc tag monoclonal antibody and anti-mouse
Alexa488secondaryantibody(coloredgreen).Thenucleiarestained
with propidium iodide (colored red). It is shown that, in the absence
of added copper, the expressed ATP7A (A) and ATP7B (B) proteins
(green)aremostlyvisiblenearthenuclei(redcolor),correspondingto
the Golgi and trans-Golgi network. In the presence ofadded copper,
ATP7A (C) is partly retained near the nuclei and partly targeted to
plasmamembranes;notraffickingvesiclesareobserved.Ontheother
hand, ATP7B (D) is associated with numerous trafficking vesicles
throughout the cytoplasm, with no significant plasma membrane
association. The bar is 10 μm.
FIGURE 8: Association of ATP7A protein with the plasma mem-
brane of COS-1 cells. COS-1 cells were infected with optimal
rAdATP7AmycviraltitersasexplainedinExperimentalProcedures,
and 200 μM copper was added. After 24 h, the cells were fixed with
paraformaldehyde, permeabilized with Triton X-100, and stained
(see Experimental Procedures). Immunostaining of ATP7A with the
anti-myc tag antibody is shown in green (A), and plasma membrane
immunostainingwiththeanti-PanCadherinantibodyisshowninred
(B).Nuclear stainingwithDAPI isshown inblue(C). The overlay in
panel C demonstrates colocalization of ATP7A and anti-Pan Cad-
herin antibodies in the plasma membrane. The bar is 10 μm.Article Biochemistry, Vol. 49, No. 46, 2010 10011
endoplasmic reticulum membranes and then migrate and fuse
with the plasma membrane by exocytosis, resulting in protein
membrane assembly and stabilization. This would explain the
ATP7A membrane association observed in our experiments
(Figure 8). On the other hand, no glycosylation sites are noted
in the ATP7B sequence, with the exception of Asn303AsnSer and
Table 1: ATP7A (7A) Sequence Segments, Including Glycosylation Motifs (bold and underlined) and ATP (7B) Sequence Segments Aligned with the
Corresponding ATP7B Segments
a
aAsterisks denote identical residues, colons conserved substitutions, and periods semiconserved substitutions (Clustal W).10012 Biochemistry, Vol. 49, No. 46, 2010 Liu et al.
Asn353LeuThr within the NMBD, predicted to face the cytosol
upon insertion of the protein in the plasma membrane.
Glycosylation of ATP7A was originally implied in studies
by Yamaguchi et al. (22).
In our experiments for expression in COS-1 cells, we found
that phosphorylation of serine residues (“alkaline resistant
phosphorylation”) is more prominent in ATP7B than in ATP7A
(Figures 2, 4, and 6). This is again consistent with sequence
analysis, considering that of the serine residues (Ser478, Ser481,
Ser1121, and Ser1453) shown to undergo phosphorylation in
ATP7B (15),onlySer1486 (correspondingtoSer1453 ofATP7B)
is present in the ATP7A sequence. Phosphorylation of serine
residues is likely to play an important role in copper ATPase’s
regulation and trafficking (23), and in our experiments, the high
level of serine phosphorylation may account for the high density
ofATP7B associated with trafficking vesicles inthe cytoplasmof
cellssubjectedtoacopperload(Figure7D).Itiswell-knownthat
phosphorylation is involved in regulation and localization of
membrane-bound proteins (24, 25). Phosphorylation of Thr947
in the carboxyl terminus of another P-type ATPase (plasma
membrane H
þ-ATPase AHA2) is required for high-affinity
binding of regulatory proteins (26). It may be relevant that in
ATP7B, Ser1453 is followed by a unique COOH terminus three-
leucinezippermotif(onlytwo leucines followSer1486 ofATP7A),
which is known to play a role in scaffolding and receptor
targeting (27).
In conclusion, our experiments indicate that the catalytic
properties of ATP7A and ATP7B, including intermediate
formation and turnover of the phosphorylated aspartyl
residue, are quite similar. However, different levels of glyco-
sylation and serine phosphorylation are likely to contribute
to specific trafficking patterns and membrane targeting of
ATP7A and ATP7B, observed when the two proteins are
e x p r e s s e di nt h es a m em a m m a l i a nc e l lt y p e .
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